Profile: Akers Biosciences Inc (AKR.L)

AKR.L on London Stock Exchange

282.50GBp
12 Sep 2014
Price Change (% chg)

0.00p (+0.00%)
Prev Close
282.50p
Open
282.50p
Day's High
--
Day's Low
--
Volume
50,000
Avg. Vol
6,727
52-wk High
702.00p
52-wk Low
195.00p

Search Stocks
Akers Biosciences, Inc. develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring healthcare information both rapidly and directly to the patient or healthcare provider. The Company’s primary focus is the development and sale of the disposal diagnostic testing devices to facilitate time sensitive therapeutic decisions. The Company’s main products are a disposal breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposal breathalyzer test that measures free radical activity in the human body. The Company’s products include BreathScan, BreathScan PRO, METRON, VIVO, Heparin/PF4 Antibody Serum Panels, and Breath Ketone.

Company Address

Akers Biosciences Inc

201 Grove Rd
WEST DEPTFORD   NJ   08086-2231
P: +1856.8488698

Search Stocks